Patent intelligence · US
US 8642081
Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
Patent details — US 8642081
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 4, 2014
- Expiration
- Jan 30, 2034
- Applicant
- TAKEDA NYCOMED AS
- Claims
- 37
- CPC classes
- A61K, A61K9/0056, A61K9/0095, A61K9/2866
Quick answer
US 8642081 (Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance) is held by TAKEDA NYCOMED AS. Status: granted. Granted Feb 4, 2014. Expires Jan 30, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- TAKEDA NYCOMED AS
- Grant date
- Expiration
- Claims
- 37
- CPC classes
- A61K, A61K9/0056, A61K9/0095, A61K9/2866
More from TAKEDA NYCOMED AS
Related pharmaceutical patents in our USPTO index.
-
US 12428403
N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists
granted -
US 12421188
Heterocyclic compound and use thereof
granted -
US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted -
US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted -
US 12415782
Heterocyclic compound and use thereof
granted -
US 12409210
CNS delivery of therapeutic agents
granted -
US 12404237
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
granted -
US 12403154
Administration of sting agonist and checkpoint inhibitors
granted
Frequently asked questions
What is US patent 8642081?
US 8642081 (Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance) is held by TAKEDA NYCOMED AS. Status: granted. Granted Feb 4, 2014. Expires Jan 30, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8642081?
TAKEDA NYCOMED AS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1,436 pharmaceutical patents for this assignee.
When does US 8642081 expire?
Our index shows an expiration date of Jan 30, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.